đź’ˇ A Step Closer to Making Precision Resynchronization Therapy a Reality for All Patients: Corify at Clinical Guidelines
We are proud to announce that Corify’s Imageless ECGI technology, developed in collaboration with the COR Research Group at Universitat Politècnica de València, has been featured in the latest Clinical Consensus Statement by the European Society of Cardiology (ESC) on conduction system pacing indications.
🧠Why is this important?
This consensus is one of the most influential clinical references in the field of cardiac pacing—endorsed by European Heart Rhythm Association, Heart Rhythm Society, Canadian Heart Rhythm Society, Asia Pacific Heart Rhythm Society, and Sociedad Latinoamericana del Ritmo. It guides treatment decisions for thousands of clinicians managing heart failure patients in need of physiological pacing worldwide.
🔍 What’s new?
For the first time, Figure 4 of the document includes electrical activation maps obtained using Corify’s Imageless ECGI—a non-invasive, CT-free solution that delivers high-resolution insights into cardiac conduction without radiation, contrast, or contact. It’s fast, scalable, and designed for real-world clinical use.
đź’™ What does this mean for clinicians and patients?
It means we’re moving closer to a future where personalized cardiac resynchronization therapy (CRT) is not limited to top-tier centers, but becomes accessible to hospitals and EP labs everywhere. Because every patient—regardless of where they are—deserves precision and personalization.
🚀 What’s next?
We continue to work hand in hand with clinical leaders to validate, refine, and expand the use of Imageless ECGI in resynchronization and beyond. Our mission is clear: empower more professionals to treat smarter, so that more patients can live better.
đź”— Discover how Corify is redefining non-invasive cardiac mapping at our website
To all the physicians and researchers contributing to this progress: this recognition is yours, too.